16-18
Jun
2026
8-10
Jul
2026
25-27
Aug
2026
6-8
Oct
2026
14-16
Dec
2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
H1.C50
Caregen Co.,Ltd.
About Caregen Co.,Ltd.
Certifications
Categories
Meet us at
-
Country/Region:Korea, Republic Of
-
Founded:2001
-
On CPHI since:2016
-
Certificates:3
-
Employees:100 - 249
Company types
Primary activities
Products from Caregen Co.,Ltd. (6)
-
Product CG-P5
First-in-Class VEGFR2-Inhibiting Peptide Eye Drop for Wet Age-Related Macular Degeneration
Product Overview: A New Standard for Non-Invasive Retinal Therapy
CG-P5 is a first-in-class VEGFR2-inhibiting biomimetic peptide developed as a topical eye drop for the treatment of wet age-related m... -
Product CG-T1
Peptide-Based Topical Therapeutic for Dry Eye Disease (DED)
Product Overview: A Restorative Approach to Dry Eye Disease
CG-T1 is a next-generation peptide-based topical therapy for dry eye disease, advancing toward Phase 2 clinical development in the United States following successfu... -
Product Korglutide
Korglutide is a next-generation oral dual GLP-1R/IGF-1R peptide designed to support safe and muscle-preserving weight loss as a non-injectable nutraceutical alternative.
Product Overview
Korglutide is a synthetic dual GLP-1R and IGF-1R agonist peptide developed by Caregen for weight management and ... -
Product MyoKi
MyoKi is an oral anti-myostatin peptide designed to support muscle mass and strength, enabling safe and effective muscle health management across all age groups.
Product OverviewMyoKi is a peptide-based nutraceutical developed to support muscle preservation and functional performance t... -
Product ProGsterol
ProGsterol is an oral peptide-based nutraceutical designed to improve insulin receptor sensitivity and regulate glucose metabolism, supporting overall metabolic balance.
Product Overview
ProGsterol is a peptide-based nutraceutical developed by Caregen for metabolic disorders, including insulin re... -
Product CG-Luxidase
CG-Luxidase is a proprietary peptide-based delivery platform designed to enhance the penetration and distribution of active compounds by transiently modulating the hyaluronic acid (HA) network within the extracellular matrix (ECM).
As a water-soluble synthetic decapeptide (INCI: Decapeptide-51),...
Caregen Co.,Ltd. Resources (1)
-
Video Korglutide: A Novel Breakthrough Sema/Liraglutide Replacement Oral Peptide for Weight Loss
Clinical Approaches in Type 2 diabetes, Weight loss, and Fatty Liver Disease(NASH)





